The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1339
May 31, 2010
View Complete Issue         Table of Contents 2019 
Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
May 31, 2010 (Issue: 1339)
Two combinations of an inhaled corticosteroid with an inhaled long-acting beta2-agonist are approved by the FDA for use in patients with COPD: fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol (Symbicort). A Medical Letter reader has...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Safety of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Article code: 1339b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.